Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings' (ARCT) quarterly Other Non-Current Assets came in at $2.0 million in Q1 2026, down 88.97% YoY from $18.4 million in Q1 2025, and up 7.59% on a QoQ basis from $1.9 million in Q4 2025.

Analysis

Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Arcturus Therapeutics Holdings (ARCT) has 9 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 88.97% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 88.97% YoY) and the FY2025 annual result came in at $1.9 million, changed 0.0% from the prior year.
  • Other Non-Current Assets climbed to $2.0 million in Q1 2026, from $1.9 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $22.1 million in Q3 2023 to a low of $1.9 million in Q4 2023.
  • A 5-year average of $4.1 million and a median of $2.0 million in 2026 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1842.06% — and 2024, when it slumped 91.48%.
  • Tracing ARCT's Other Non-Current Assets over 5 years: stood at $2.1 million in 2022, then declined by 9.98% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025, then rose by 7.59% to $2.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $2.0 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Arcturus Therapeutics Holdings 449.65 Mn 258.17 Mn - 2.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.03 Mn
Mar 31, 2026 2.03 Mn
Dec 31, 2025 1.89 Mn
Sep 30, 2025 1.89 Mn
Jun 30, 2025 1.89 Mn
Mar 31, 2025 18.39 Mn
Dec 31, 2024 1.89 Mn
Sep 30, 2024 1.89 Mn
Jun 30, 2024 1.89 Mn
Mar 31, 2024 1.89 Mn
Dec 31, 2023 1.89 Mn
Sep 30, 2023 22.13 Mn
Jun 30, 2023 2.13 Mn
Mar 31, 2023 2.12 Mn
Dec 31, 2022 2.09 Mn
Sep 30, 2022 2.08 Mn
Jun 30, 2022 2.08 Mn
Mar 31, 2022 2.08 Mn
Dec 31, 2021 2.08 Mn
Sep 30, 2021 2.07 Mn